Guardant Health Income Statement (2017-2026) | GH

Income Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
94.78M108.11M96.10M109.14M117.40M126.89M128.71M137.15M143.03M155.05M168.49M177.24M191.48M201.81M203.47M232.09M265.20M281.27M301.67M334.98M
Cost of Revenue (Quarter)
65.30M72.42M74.49M-212.21M74.72M81.20M93.59M-249.51M104.92M115.95M
Gross Profit (Quarter)
103.19M104.81M116.99M414.02M128.75M150.88M171.61M530.78M196.75M219.03M
Operating items
Research & Development (Quarter)
70.97M73.02M81.76M73.60M80.37M155.40M76.12M90.36M93.85M89.86M83.80M83.10M97.88M110.72M88.52M119.59M127.38M143.38M91.04M189.95M
Selling, General & Administrative (Quarter)
50.05M40.27M41.27M43.68M41.12M37.89M40.45M41.52M36.17M37.66M38.65M40.46M49.13M51.88M46.95M50.26M53.27M60.93M57.93M61.66M
Other Operating Expenses (Quarter)
96.41M-99.78M146.20M145.72M154.29M161.79M165.17M179.04M168.65M183.54M197.76M274.05M212.48M
Operating Expenses (Quarter)
202.07M206.32M219.44M239.47M262.00M273.01M262.77M256.77M256.57M352.56M268.17M277.85M308.80M327.78M314.51M338.50M364.19M402.07M423.01M464.10M
Operating Income (Quarter)
-107.29M-98.21M-123.34M-130.32M-144.60M-146.12M-134.06M-119.62M-113.54M-197.51M-99.68M-100.62M-117.33M-125.97M-111.04M-106.41M-98.99M-120.81M-121.35M-129.12M
EBIT (Quarter)
-107.29M-98.21M-123.34M-130.32M-144.60M-146.12M-134.06M-119.62M-113.54M-197.51M-99.68M-100.62M-117.33M-125.97M-111.04M-106.41M-98.99M-120.81M-121.35M-129.12M
Non-operating items
Interest & Investment Income (Quarter)
0.69M0.65M0.78M1.39M1.75M2.15M3.06M6.73M11.69M13.89M14.87M13.91M13.26M11.65M9.11M7.56M7.39M10.03M11.15M10.20M
Other Non Operating Income (Quarter)
-0.19M25.90M-0.05M0.38M-18.39M5.28M-1.65M41.26M16.89M-3.32M-29.12M-15.14M-3.01M4.67M7.85M-0.03M-0.05M-18.27M-0.16M0.31M
Net income details
EBT (Quarter)
-107.43M-72.30M-123.25M-228.99M-161.88M-139.33M-133.29M-72.28M-85.61M-187.58M-114.58M-102.50M-107.72M-110.29M-94.87M-99.86M-92.59M-130.22M-111.70M-119.96M
Tax Provisions (Quarter)
0.10M0.01M-0.02M0.45M0.12M0.60M0.24M0.50M0.49M-0.54M0.41M0.13M0.03M0.72M0.29M0.04M0.14M-1.73M0.37M0.18M
Profit After Tax (Quarter)
-107.53M-72.31M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Income from Non-Controlling Interests (Quarter)
18.60M
Income from Continuing Operations (Quarter)
-107.53M-72.31M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Consolidated Net Income (Quarter)
-107.53M-72.31M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Income towards Parent Company (Quarter)
-107.53M-72.31M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-107.53M-90.91M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Additional items
EPS (Basic) (Quarter)
-1.06-0.90-1.21-2.25-1.58-1.37-1.30-0.67-0.73-1.67-0.94-0.84-0.88-0.90-0.77-0.80-0.74-1.02-0.85-0.90
EPS (Diluted) (Quarter)
-1.06-0.90-1.21-2.25-1.58-1.37-1.30-0.67-0.73-1.67-0.94-0.84-0.88-0.90-0.77-0.80-0.74-1.02-0.85-0.90
Shares Outstanding (Quarter)
101.42M101.31M101.85M102.05M102.29M102.18M102.66M108.81M117.74M111.99M121.71M122.45M123.05M122.75M123.87M124.11M124.81M125.37M131.27M132.87M
Shares Outstanding (Diluted) (Quarter)
101.42M101.31M101.85M102.05M102.29M102.18M102.66M108.81M117.74M111.99M121.71M122.45M123.05M122.75M123.87M124.11M124.81M125.37M131.27M132.87M
Shares Outstanding (Entity) (Quarter)
101.62M101.77M101.90M102.19M102.41M102.62M102.71M117.66M117.85M121.63M121.79M122.97M123.16M123.99M124.62M125.45M125.98M130.64M131.51M133.61M
EBITDA (Quarter)
-107.29M-98.21M-123.34M-130.32M-144.60M-146.12M-134.06M-119.62M-113.54M-197.51M-99.68M-100.62M-117.33M-125.97M-111.04M-106.41M-98.99M-120.81M-121.35M-129.12M
Interest Expenses (Quarter)
294.21M2.57M115.46M286.36M279.85M4.77M267.37M259.63M253.77M0.65M1.11M1.11M1.11M5.96M0.79M113.88M0.94M6.98M261.06M416.38M
Tax Rate (Quarter)
-0.09%-0.02%0.02%-0.19%-0.07%-0.43%-0.18%-0.69%-0.57%0.29%-0.35%-0.13%-0.03%-0.65%-0.31%-0.04%-0.15%1.33%-0.33%-0.15%